Dordaviprone
CAS 1616632-77-9Small Molecule
Overview
Dordaviprone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297310).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Dordaviprone expires 30 Jan 2037 and exclusivity 6 Aug 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 11-benzyl-7-[(2-methylphenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one
- Canonical SMILES
- CC1=CC=CC=C1CN2C(=O)C3=C(CCN(C3)CC4=CC=CC=C4)N5C2=NCC5
- InChIKey
- VLULRUCCHYVXOH-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.